Home/Filings/4/0000899243-21-046316

4//SEC Filing

Medicxi Growth I LP 4

Accession 0000899243-21-046316

CIK 0001847903other

View on SEC.gov Company Profile

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 5:11 PM ET

Size

23.2 KB

Accession

0000899243-21-046316

Insider Transaction Report

Form 4

Period: 2021-11-26

Centessa Pharmaceuticals plcCNTA

Medicxi Ventures Management (Jersey) Ltd

10% Owner

Transactions

Purchase
Ordinary Shares
2021-11-29$11.70/sh+1,315$15,386→ 90,476 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-29$11.70/sh+55,391$648,091→ 3,808,543 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-26$11.34/sh+274$3,106→ 89,161 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-26$11.34/sh+11,543$130,843→ 3,753,152 total(indirect: See footnote)

Holdings

Ordinary Shares
(indirect: See footnote)
4,398,519
Ordinary Shares
(indirect: See footnote)
9,403,092
Ordinary Shares
(indirect: See footnote)
236,108
Ordinary Shares
(indirect: See footnote)
55,677

Medicxi Growth I LP

10% Owner

Transactions

Purchase
Ordinary Shares
2021-11-26$11.34/sh+11,543$130,843→ 3,753,152 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-26$11.34/sh+274$3,106→ 89,161 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-29$11.70/sh+55,391$648,091→ 3,808,543 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-29$11.70/sh+1,315$15,386→ 90,476 total(indirect: See footnote)

Holdings

Ordinary Shares
(indirect: See footnote)
9,403,092
Ordinary Shares
(indirect: See footnote)
55,677
Ordinary Shares
(indirect: See footnote)
4,398,519
Ordinary Shares
(indirect: See footnote)
236,108

Medicxi Growth Co-Invest I LP

10% Owner

Transactions

Purchase
Ordinary Shares
2021-11-26$11.34/sh+274$3,106→ 89,161 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-29$11.70/sh+55,391$648,091→ 3,808,543 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-26$11.34/sh+11,543$130,843→ 3,753,152 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-29$11.70/sh+1,315$15,386→ 90,476 total(indirect: See footnote)

Holdings

Ordinary Shares
(indirect: See footnote)
4,398,519
Ordinary Shares
(indirect: See footnote)
9,403,092
Ordinary Shares
(indirect: See footnote)
236,108
Ordinary Shares
(indirect: See footnote)
55,677

Medicxi Growth I GP Ltd

10% Owner

Transactions

Purchase
Ordinary Shares
2021-11-26$11.34/sh+11,543$130,843→ 3,753,152 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-26$11.34/sh+274$3,106→ 89,161 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-29$11.70/sh+55,391$648,091→ 3,808,543 total(indirect: See footnote)
Purchase
Ordinary Shares
2021-11-29$11.70/sh+1,315$15,386→ 90,476 total(indirect: See footnote)

Holdings

Ordinary Shares
(indirect: See footnote)
9,403,092
Ordinary Shares
(indirect: See footnote)
236,108
Ordinary Shares
(indirect: See footnote)
4,398,519
Ordinary Shares
(indirect: See footnote)
55,677

Footnotes (7)

[F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
[F2]Held by Medicxi Growth I LP, a Jersey limited partnership ("Medicxi Growth I"). Medicxi Growth I GP Limited, a Jersey limited liability company ("MGI GP"), is the sole managing general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited, a Jersey limited liability company ("Medicxi Manager") is the sole manager of Medicxi Growth I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.
[F3]Held by Medicxi Growth Co-Invest I LP, a Jersey limited partnership ("Medicxi Growth Co-Invest I"). MGI GP is the sole managing general partner of Medicxi Growth Co-Invest I, and Medicxi Manager is the sole manager of Medicxi Growth Co-Invest I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.
[F4]Held by Medicxi Ventures I LP, a Jersey limited partnership ("Medicxi Ventures I"). Medicxi Ventures I GP Limited, a Jersey limited liability company ("MVI GP"), is the sole managing general partner of Medicxi Ventures I, and Medicxi Manager is the sole manager of Medicxi Ventures I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi Ventures I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.
[F5]Held by Medicxi Co-Invest I LP, a Jersey limited partnership ("Medicxi Co-Invest I"). MVI GP is the sole managing general partner of Medicxi Co-Invest I, and Medicxi Manager is the sole manager of Medicxi Co-Invest I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi Co-Invest I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.
[F6]Held by Medicxi Secondary I LP, a Jersey limited partnership ("Medicxi Secondary I"). Medicxi Secondary I GP Limited, a Jersey limited liability company ("MSI GP"), is the sole managing general partner of Medicxi Secondary I, and Medicxi Manager is the sole manager of Medicxi Secondary I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi Secondary I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.
[F7]Held by Medicxi Secondary Co-Invest I LP, a Jersey limited partnership ("Medicxi Secondary Co-Invest I"). MSI GP is the sole managing general partner of Medicxi Secondary Co-Invest I, and Medicxi Manager is the sole manager of Medicxi Secondary Co-Invest I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi Secondary Co-Invest I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

→

Entity typeother

IncorporatedJersey

Related Parties

filerCIK 0001690310

Filing Metadata

Form type: 4
Filed: Nov 29, 7:00 PM ET
Accepted: Nov 30, 5:11 PM ET
Size: 23.2 KB

View on SEC.gov